FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease
β Scribed by Dorkin, Trevor J; Robinson, Mary C; Marsh, Colin; Bjartell, Anders; Neal, David E; Leung, Hing Y
- Book ID
- 110062059
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 560 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
TENB2 encodes a putative transmembrane proteoglycan, related to the EGF/heregulin family of growth factors and follistatin, which has been identified through the application of a differential display technique to a xenograft model of prostate cancer. Northern analysis and competitive PCR were used t
A comparison has been made of the phenotypic expression of MHC class I antigens with the corresponding HLA-A genotype in 15 cases of benign prostatic hyperplasia (BPH) and 34 cases of primary locally invasive prostatic carcinoma. Expression of class 1 protein, detected by immunocytochemistry, was pa
## Abstract To elucidate the mechanism of androgenβdependent cellular proliferation in prostate cancer, androgenβdependent alterations of individual cell cycle regulatory proteins in the androgenβsensitive prostate cancer cell line LNCaP were evaluated. LNCaP cells were deprived of androgens by cul